TScan Therapeutics (TCRX) Selling, General & Administrative (2020 - 2026)
TScan Therapeutics (TCRX) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 322.55 Mn |
| 10 | TScan Therapeutics | 102.89 Mn | -25.17 Mn | - | 8.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.22 Mn |
| Dec 31, 2025 | 6.39 Mn |
| Sep 30, 2025 | 7.87 Mn |
| Jun 30, 2025 | 9.10 Mn |
| Mar 31, 2025 | 8.63 Mn |
| Dec 31, 2024 | 8.02 Mn |
| Sep 30, 2024 | 7.41 Mn |
| Jun 30, 2024 | 7.77 Mn |
| Mar 31, 2024 | 7.08 Mn |
| Dec 31, 2023 | 6.16 Mn |
| Sep 30, 2023 | 5.89 Mn |
| Jun 30, 2023 | 6.53 Mn |
| Mar 31, 2023 | 7.77 Mn |
| Dec 31, 2022 | 6.14 Mn |
| Sep 30, 2022 | 4.91 Mn |
| Jun 30, 2022 | 4.81 Mn |
| Mar 31, 2022 | 4.49 Mn |
| Dec 31, 2021 | 4.45 Mn |
| Sep 30, 2021 | 4.05 Mn |
| Jun 30, 2021 | 2.73 Mn |